Traws Pharma Stock Quote TRAW - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.4646

Bid

4.22

Ask

5.50

Volume

5,986

4.3598 Day's Range 4.645

4.155 52 Week Range 24.75

Market Cap

13.507M

Previous Close

4.51

Open

4.55

Last Trade

4.75

Last Trade Time

Financial Volume

$ 27,430

VWAP

4.5824

Average Volume (3m)

54,629

Shares Outstanding

3,025,430

Dividend Yield

PE Ratio

-0.71

Earnings Per Share (EPS)

-6.26

Revenue

226k

Net Profit

-18.95M

Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, pr... Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.onconova.com

Headquarters

Wilmington, Delaware, USA

Founded

Traws Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TRAW. The last closing price for Traws Pharma was $4.51. Over the last year, Traws Pharma shares have traded in a share price range of $ 4.155 to $ 24.75.

Traws Pharma currently has 3,025,430 shares outstanding. The market capitalization of Traws Pharma is $13.64 million. Traws Pharma has a price to earnings ratio (PE ratio) of -0.71.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.9554	-17.6273062731	5.42	5.42	4.155	6246	4.69927149	CS
4	-0.6454	-12.6301369863	5.11	5.96	4.155	7065	5.10409241	CS
12	-5.1179	-53.4088181581	9.5825	9.75	4.155	54629	7.35810729	CS
26	-11.7854	-72.5255384615	16.25	17.75	4.155	76863	10.22186107	CS
52	-20.2854	-81.9612121212	24.75	24.75	4.155	82725	12.65959542	CS
156	-20.2854	-81.9612121212	24.75	24.75	4.155	82725	12.65959542	CS
260	-20.2854	-81.9612121212	24.75	24.75	4.155	82725	12.65959542	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	$ 8.26 (89.02%)	2.03M
XCURExicure Inc	$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	$ 0.0201 (-0.50%)	425.38M
NVDANVIDIA Corporation	$ 141.95 (-3.22%)	236.51M
SMCISuper Micro Computer Inc	$ 33.15 (11.62%)	159.61M
VRPXVirpax Pharmaceuticals Inc	$ 0.5501 (-6.72%)	159.39M
SOUNSoundHound AI Inc	$ 8.24 (18.05%)	107.91M